Mg2+-induced endothelium-dependent relaxation of blood vessels and blood pressure lowering: Role of NO

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Yang, Zhi Wei ^a   Gebrewold, Asefa ^a   Nowakowski, Maja ^a   Altura, Bella T ^a,b   Altura, Burton M ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b SUNY Downstate Medical Center   (United States)

Author keywords

Calcium; Endothelium derived relaxing factor; Guanosine 3',5' cyclic monophosphate; Microvessels; Rat aorta; Vasodilatation

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; MAGNESIUM ION; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM; MAGNESIUM BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0034071198     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.3.r628     Document Type: Article

References (42)

1. Allen, S., S. Khan, S.-P. Tam, M. Koschinsky, P. Taylor, and M. Yacoub. Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity. FASEB J. 12: 1765-1776, 1998.
2. Altura, B. M. Magnesium and regulation of contractility of vascular smooth muscle. Adv. Microcirc. 11: 77-113, 1982.
3. Altura, B. M., and B. T. Altura. Differential effects of substrate depletion on drug-induced contractions of rabbit aorta. Am. J. Physiol. 219: 1698-1705, 1970.
4. Altura, B. M., and B. T. Altura. Influence of magnesium on drug-induced contractions and ion content in rabbit aorta. Am. J. Physiol. 220: 938-944, 1971.
5. Altura, B. M., and B. T. Altura. Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Federation Proc. 40: 2672-2679, 1981.
6. Altura, B. M., and B. T. Altura. Role of magnesium in the pathogenesis of hypertension update: relationship to its actions on cardiac, vascular smooth muscle, and endothelial cells. In: Hypertension: Pathophysiology, Diagnosis, and Management (2nd Ed.), edited by J. H. Laragh and B. M. Brenner. New York: Raven, 1995, chapt. 72, p. 1213-1242.
7. 2+ movements. Can. J. Physiol. Pharmacol 60: 729-745, 1987.
8. Altura, B. M., B. T. Altura, A. Gebrebold, H. Ising, and T. Gunther. Magnesium-deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science 223: 1315-1317, 1984.
9. Altura, B. M., and N. Chand. Bradykinin induced relaxation of renal and pulmonary arteries is dependent upon intact endothelial cells. Br. J. Pharmacol 74: 10-11, 1981.
10. Altura, B. T., and B. M. Altura. Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxations of tone in cerebral arteries. Neurosci. Lett. 20: 323-327, 1980.
11. Altura, B. T., and B. M. Altura. Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br. J. Pharmacol. 91: 449-451, 1987.
12. Altura, B. T., and B. M. Altura. Measurement of ionized magnesium with a new ion-selective electrode in healthy and diseased human subjects. Magn. Trace Elem. 10:90-98, 1991.
13. 2+ release from internal stores in vascular endothelial cells. Biochem. J. 295: 357-366, 1993.
14. Cartier, R., C. Hollmann, J. Buluran, and F. Dagenais. Effects of modified St. Thomas's Hospital solution on coronary artery endothelium dependent relaxation in the isolated rat heart. Can. J. Cardiol. 11: 53-58, 1995.
15. Chand, N., and B. M. Altura. Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: role in lung vascular diseases. Science 213: 1367-1369, 1981.
16. 2+ currents of capillary endothelial cells from rat brain. FEBS. Lett. 394: 335-339, 1996.
17. 2+ entry into vascular smooth muscle cells. Magnesium Res. 10: 101-106, 1997.
18. Furchgott, R. F. Studies on relaxation of rabbit aorta by sodium nitrite: basis for the proposal that the acid-activatable component of the inhibitory factor from retractor penis is inorganic nitrate and the endothelium-derived relaxing factor is nitric oxide. In: Mechanisms of Vasodilatation, edited by P. M. Vanhoutte. New York: Raven, 1988, p. 401-414.
19. Furchgott, R. F., and J. V. Zawadzki. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond.) 288: 373-376, 1980.
20. Green, S. J., C. A. Nacy, and M. S. Meltzer. Cytokine-induced synthesis of nitrogen oxide: a protective host response to Leishmania and other intracellular pathogens. J. Leukoc. Biol. 50: 93-103, 1991.
21. Hazard, R., and L. Wurmser. Actions des sel de magnésium sur les vasoconstricteurs rénaux. Compte Rendus Soc. Biol. 110: 525-528, 1932.
22. Ignarro, L., and P. J. Kadowitz. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol. 25: 171-191, 1985.
23. Ignarro, L. J., R. E. Byrns, and K. S. Wood. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. In: Mechanisms of Vasodilatation, edited by P. M. Vanhoutte. New York: Raven, 1988, p. 427-435.
24. Kolb, J. P., N. Paul-Eugene, C. Damais, K. Yamaoka, J. C. Drapier, and B. Dugas. Interleukin-4 stimulates cGMP production by IFN-γ-activated human monocytes. J. Biol. Chem. 269: 9811-9816, 1994.
25. Ku, D. D., and H. S. Ann. Different effects of magnesium on basal and agonist-induced EDRF relaxation in canine coronary arteries. J. Cardiovasc. Pharmacol. 17: 999-1006, 1991.
26. 2+-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat. Eur. J. Pharmacol. 258: 167-172, 1994.
27. Main, K. B., and W. Martin. The inhibitory effect of 3-amino-1,2,4-triazol on relaxation induced by hydroxylamine and sodium azide but not hydrogen peroxide or glyceryl trinitrate in rat aorta. Br. J. Pharmacol. 116: 3302-3308, 1995.
28. Marchenko, S. M., and S. O. Sage. Calcium-activated potassium channels in the endothelium of intact rat aorta. J. Physiol. (Lond.) 492: 53-60, 1996.
29. 2+ in guinea-pig basilar artery smooth muscle cells. J. Physiol. (Lond.) 492: 359-376, 1996.
30. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
31. Mordes, J. P., and W. E. C. Wacker. Excess magnesium. Pharmacol. Rev. 29: 273-300, 1978.
32. Nakaigawa, Y., S. Akazawa, R. Shimizu, R. Ishii, S. Ikeno, S. Inoue, and R. Yamato. Effects of magnesium sulphate on the cardiovascular system, coronary circulation and myocardial metabolism in anaesthetized dogs. Br. J. Anaesth. 79: 363-368, 1997.
33. Nishio, A., A. Gebrewold, B. T. Altura, and B. M. Altura. Comparative effects of magnesium salts on reactivity of arterioles and venules to constrictor agents: an in situ study. J. Pharmacol. Exp. Ther. 246: 859-865, 1988.
34. Nishio, A., A. Gebrewold, B. T. Altura, and B. M. Altura. Comparative vasodilator effects of magnesium salts on rat mesenteric arterioles and venules. Arch. Int. Pharmacodyn. Ther. 298: 139-163, 1989.
35. Palmer, R., and S. Moncada. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun. 158: 348-352, 1989.
36. Sjögren, A., and L. Edvinson. The influence of magnesium on the release of calcium from intracellular depots in vascular smooth muscle cells. Pharmacol. Toxicol. 62: 17-21, 1988.
37. 2+ on endothelin-1- and 5-hydroxytryptamine-elicited responses in goat cerebrovascular bed. J. Cardiol. Pharmacol. 23: 1004-1010, 1994.
38. + channel in cultured vascular endothelial cells. Pflügers Arch. Eur. J. Physiol 422: 66-74, 1992.
39. Whitney, G., D. Throckmorton, C. Isales, Y. Takuwa, J. Yeh, H. Resmussen, and C. Brophy. Kinase activation and smooth muscle contraction in the presence and absence of calcium. J. Vase. Surg. 22: 37-44, 1995.
40. Burke-Wolin, T., C. J. Abate, M. S. Wolin, and G. H. Gurtner. Hydrogen peroxide-induced pulmonary vasodilatation: role of guanosine 3′,5′-cyclic monophosphate. Am. J. Physiol. Lung Cell. Mol. Physiol. 261: L393-L398, 1991.
41. +. Br. J. Pharmacol. 105: 305-310, 1992.
42. 2+ in EDRF release in rat aorta. J. Vasc. Res. 31: 18-24, 1994.